Our new board appears not to have gotten off to a good start selling off our most important profitable asset in the US an excellent strategic move to grow the company in the States further establishing ourselves with impressive further development / expansion of existing manufacturing Pharma plant Metrics this plus a strong client base consisting of a number of US Pharma companies under contract . This extremely lucrative business helped getting Maynes name known in a hugely populated country like the US . Taking on Nextstellis , growing debt . Syndicated lenders no doubt using Metrics as security probably behind debt needing to be repaid in its entirety not hard to see management left with little option but blow up Maynes years of real growth . The story management gave holders seems market investors didn't buy it .
MYX Price at posting:
27.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)